Roland Schwarting
- Immunology top 0.5%
- Pathology and Forensic Medicine top 0.2%
- Oncology top 1%
- Molecular Biology top 5%
- Immunology and Allergy top 0.2%
- Co-authors
- Johannes GerdesH SteinH. SteinBrunangelo FaliniGeorges DelsolTimothy A. SpringerHilmar LemkeGorm Pallesen
- Topics
- Monoclonal and Polyclonal Antibodies Research (30 papers)Lymphoma Diagnosis and Treatment (20 papers)Chronic Lymphocytic Leukemia Research (11 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationThe Journal of Experimental Medicine
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Roland Schwarting
95 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Immunology 3.2k
- Pathology and Forensic Medicine 3.0k
- Oncology 2.2k
- Molecular Biology 1.4k
- Immunology and Allergy 1.3k
Countries citing papers authored by Roland Schwarting
This map shows the geographic impact of Roland Schwarting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Schwarting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Schwarting more than expected).
Fields of papers citing papers by Roland Schwarting
This network shows the impact of papers produced by Roland Schwarting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Schwarting. The network helps show where Roland Schwarting may publish in the future.
Co-authorship network of co-authors of Roland Schwarting
This figure shows the co-authorship network connecting the top 25 collaborators of Roland Schwarting. A scholar is included among the top collaborators of Roland Schwarting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Schwarting. Roland Schwarting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 88 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 13 | |
| 7 | 38 | |
| 8 | 82 | |
| 9 | Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. | 40 |
| 10 | 11 | |
| 11 | 16 | |
| 12 | 157 | |
| 13 | 22 | |
| 14 | 424 | |
| 15 | 170 | |
| 16 | 52 | |
| 17 | 15 | |
| 18 | 37 | |
| 19 | 38 | |
| 20 | 9 |
About Roland Schwarting
Roland Schwarting is a scholar working on Immunology and Allergy, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 96 papers that have together received 8.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (30 papers), Lymphoma Diagnosis and Treatment (20 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Immunology and Allergy (1.3k citations), Pathology and Forensic Medicine (3.0k citations) and Immunology (3.2k citations). Roland Schwarting has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Johannes Gerdes, H Stein, H. Stein, Brunangelo Falini, Georges Delsol, Timothy A. Springer, Hilmar Lemke, Gorm Pallesen, K. Lennert and Nathan O’Connor. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.